PRKCD and colonic neoplasm: Previous studies have shown PKCδ participates in HDAC inhibitor-induced differentiation of colon cancer and the resultant growth arrest and apoptosis in various cancers, but the mechanisms underlying this effect remains unclear [14, 17].